From bench to clinic and back: Perspective on the 1<sup>st </sup>IQPC Translational Research conference
<p>Abstract</p> <p>Translational Research (TR) provides a set of tools and communication context for scientists and clinicians to optimize the drug discovery and development process. In the proceedings of a Princeton conference on this timely topic, the strengths and needs of this...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-12-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/2/1/44 |
_version_ | 1828428925656629248 |
---|---|
author | Hörig Heidi Pullman William |
author_facet | Hörig Heidi Pullman William |
author_sort | Hörig Heidi |
collection | DOAJ |
description | <p>Abstract</p> <p>Translational Research (TR) provides a set of tools and communication context for scientists and clinicians to optimize the drug discovery and development process. In the proceedings of a Princeton conference on this timely topic, the strengths and needs of this developing field were debated. Outcomes and key points from these discussions are summarized in this article which covers the topics of defining what we mean by translational research (both theoretically and in operational terms), ways in which to engender the TR mindset and embed it in organizations such as the pharmaceutical industry in order to optimize the impact of available technologies (including imaging methods), the scientific basis and under-pinnings of TR including genomics knowledge, information sharing, as well as examples of application to drug discovery and development. Importantly, it should be noted that collaborations and communications between the stakeholders in this field, namely academia, industry and regulatory authorities, must be strengthened in order for the promise of TR to be delivered as better therapies to patients.</p> |
first_indexed | 2024-12-10T17:25:02Z |
format | Article |
id | doaj.art-0060f5a7421243edb037b9df9ecbd61c |
institution | Directory Open Access Journal |
issn | 1479-5876 |
language | English |
last_indexed | 2024-12-10T17:25:02Z |
publishDate | 2004-12-01 |
publisher | BMC |
record_format | Article |
series | Journal of Translational Medicine |
spelling | doaj.art-0060f5a7421243edb037b9df9ecbd61c2022-12-22T01:39:51ZengBMCJournal of Translational Medicine1479-58762004-12-01214410.1186/1479-5876-2-44From bench to clinic and back: Perspective on the 1<sup>st </sup>IQPC Translational Research conferenceHörig HeidiPullman William<p>Abstract</p> <p>Translational Research (TR) provides a set of tools and communication context for scientists and clinicians to optimize the drug discovery and development process. In the proceedings of a Princeton conference on this timely topic, the strengths and needs of this developing field were debated. Outcomes and key points from these discussions are summarized in this article which covers the topics of defining what we mean by translational research (both theoretically and in operational terms), ways in which to engender the TR mindset and embed it in organizations such as the pharmaceutical industry in order to optimize the impact of available technologies (including imaging methods), the scientific basis and under-pinnings of TR including genomics knowledge, information sharing, as well as examples of application to drug discovery and development. Importantly, it should be noted that collaborations and communications between the stakeholders in this field, namely academia, industry and regulatory authorities, must be strengthened in order for the promise of TR to be delivered as better therapies to patients.</p>http://www.translational-medicine.com/content/2/1/44 |
spellingShingle | Hörig Heidi Pullman William From bench to clinic and back: Perspective on the 1<sup>st </sup>IQPC Translational Research conference Journal of Translational Medicine |
title | From bench to clinic and back: Perspective on the 1<sup>st </sup>IQPC Translational Research conference |
title_full | From bench to clinic and back: Perspective on the 1<sup>st </sup>IQPC Translational Research conference |
title_fullStr | From bench to clinic and back: Perspective on the 1<sup>st </sup>IQPC Translational Research conference |
title_full_unstemmed | From bench to clinic and back: Perspective on the 1<sup>st </sup>IQPC Translational Research conference |
title_short | From bench to clinic and back: Perspective on the 1<sup>st </sup>IQPC Translational Research conference |
title_sort | from bench to clinic and back perspective on the 1 sup st sup iqpc translational research conference |
url | http://www.translational-medicine.com/content/2/1/44 |
work_keys_str_mv | AT horigheidi frombenchtoclinicandbackperspectiveonthe1supstsupiqpctranslationalresearchconference AT pullmanwilliam frombenchtoclinicandbackperspectiveonthe1supstsupiqpctranslationalresearchconference |